Literature DB >> 24140592

Magnetic nanoparticles: a novel platform for cancer theranostics.

Abhalaxmi Singh1, Sanjeeb K Sahoo2.   

Abstract

Multifunctional nanoplatforms represent a cutting edge tool in biomedical applications as a result of their applicability in the concurrent monitoring of medical treatment. Magnetic nanoparticles (MNPs) have generated great interest in the field of cancer nanotheranostics owing to their intrinsic magnetic property that enables them to be used as contrast agents in magnetic resonance imaging and as a therapeutic system in conjunction with hyperthermia. In addition, the physical properties and biocompatibility of MNPs help them to act as efficient drug carriers for targeted therapeutic regimes. In this review, we have discussed the different theranostic applications of MNPs. Further, we have raised the current challenges associated with the clinical translation of MNPs along with future opportunities in this field.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24140592     DOI: 10.1016/j.drudis.2013.10.005

Source DB:  PubMed          Journal:  Drug Discov Today        ISSN: 1359-6446            Impact factor:   7.851


  32 in total

Review 1.  Design and synthesis of magnetic nanoparticles for biomedical diagnostics.

Authors:  Yuan Chen; Xianguang Ding; Yan Zhang; Auginia Natalia; Xuecheng Sun; Zhigang Wang; Huilin Shao
Journal:  Quant Imaging Med Surg       Date:  2018-10

Review 2.  Uptake and metabolism of iron oxide nanoparticles in brain cells.

Authors:  Charlotte Petters; Ellen Irrsack; Michael Koch; Ralf Dringen
Journal:  Neurochem Res       Date:  2014-07-11       Impact factor: 3.996

3.  Anti-HER2 VHH Targeted Magnetoliposome for Intelligent Magnetic Resonance Imaging of Breast Cancer Cells.

Authors:  Sepideh Khaleghi; Fatemeh Rahbarizadeh; Davoud Ahmadvand; Hamid Reza Madaah Hosseini
Journal:  Cell Mol Bioeng       Date:  2017-02-28       Impact factor: 2.321

Review 4.  Techniques for physicochemical characterization of nanomaterials.

Authors:  Ping-Chang Lin; Stephen Lin; Paul C Wang; Rajagopalan Sridhar
Journal:  Biotechnol Adv       Date:  2013-11-16       Impact factor: 14.227

Review 5.  Next-generation superparamagnetic iron oxide nanoparticles for cancer theranostics.

Authors:  Kai Li; Hossein Nejadnik; Heike E Daldrup-Link
Journal:  Drug Discov Today       Date:  2017-04-26       Impact factor: 7.851

6.  Determining iron oxide nanoparticle heating efficiency and elucidating local nanoparticle temperature for application in agarose gel-based tumor model.

Authors:  Rhythm R Shah; Alexander R Dombrowsky; Abigail L Paulson; Margaret P Johnson; David E Nikles; Christopher S Brazel
Journal:  Mater Sci Eng C Mater Biol Appl       Date:  2016-05-21       Impact factor: 7.328

7.  Rotating magnetic field induced oscillation of magnetic particles for in vivo mechanical destruction of malignant glioma.

Authors:  Yu Cheng; Megan E Muroski; Dorothée C M C Petit; Rhodri Mansell; Tarun Vemulkar; Ramin A Morshed; Yu Han; Irina V Balyasnikova; Craig M Horbinski; Xinlei Huang; Lingjiao Zhang; Russell P Cowburn; Maciej S Lesniak
Journal:  J Control Release       Date:  2015-12-19       Impact factor: 9.776

8.  Combining hard and soft magnetism into a single core-shell nanoparticle to achieve both hyperthermia and image contrast.

Authors:  Qiuhong Yang; Maogang Gong; Shuang Cai; Ti Zhang; Justin T Douglas; Viktor Chikan; Neal M Davies; Phil Lee; In-Young Choi; Shenqiang Ren; M Laird Forrest
Journal:  Ther Deliv       Date:  2015-10-08

9.  Magnetic Particles with Polymeric Shells Bearing Cholesterol Moieties Sensitize Breast Cancer Cells to Low Doses of Doxorubicin.

Authors:  Karolina H Markiewicz; Katarzyna Niemirowicz-Laskowska; Dawid Szymczuk; Kacper Makarewicz; Iwona Misztalewska-Turkowicz; Przemysław Wielgat; Anna M Majcher-Fitas; Sylwia Milewska; Halina Car; Agnieszka Z Wilczewska
Journal:  Int J Mol Sci       Date:  2021-05-05       Impact factor: 5.923

10.  Targeted SPION siderophore conjugate loaded with doxorubicin as a theranostic agent for imaging and treatment of colon carcinoma.

Authors:  Rahim Nosrati; Khalil Abnous; Mona Alibolandi; Jafar Mosafer; Sadegh Dehghani; Seyed Mohammad Taghdisi; Mohammad Ramezani
Journal:  Sci Rep       Date:  2021-06-22       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.